Oxaliplatin-Induced Haemolytic Anaemia: A Case Report

被引：0

作者：

Compostella, A. ^{[1
]}

Pasetto, L. M. ^{[1
]}

Ghiotto, C. ^{[1
]}

Stefani, M. ^{[1
]}

Monfardini, S. ^{[1
]}

机构：

[1] Ist Oncol Veneto, IRCCS Med Oncol 2, Via Gattamelata 64, I-35128 Padua, Italy

来源：

CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2007年 / 1卷

关键词：

acute renal failure; oxaliplatin; colon cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Oxaliplatin plus 5Fluorouracil (5FU) and leucovorin (LV) is the standard treatment of metastatic colorectal cancer (CRC). We describe a rare clinical case of acute renal failure probably oxaliplatin-related at one day from the end of the palliative treatment. A 36 year-old woman developed a stage I CRC. Five months later a liver lesion was detected and treated with FOLFOX4 schedule. Because of progression the patient underwent surgery and she repeated the Oxaliplatin-based therapy for more than one cycle. After many months of therapy, on the second day, the patient noticed urine discoloration. Immediate urinanalysis demonstrated haemoglobinuria. The patient's complete blood count exhibited signs consistent with acute hemolysis, neutrophilic leucocytosis, thrombocytopenia and acute renal failure. She was treated with blood transfusion and hemodialysis and she was managed conservatively with monitored intravenous hydration and loop diuretics. The patient gradually recovered and the results of successive hematological and biochemical tests confirmed the improvement of her condition but a cardiologic evaluation showed a iatrogenic depressed systolic function (ejection fraction of 40%).

引用

页码：105 / 109

页数：5

共 27 条

[1]

Agarwal N, 2002, J Postgrad Med, V48, P197

[2] A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders [J].

Besbas, N. ;

Karpman, D. ;

Landau, D. ;

Loirat, C. ;

Proesmans, W. ;

Remuzzi, G. ;

Rizzoni, G. ;

Taylor, C. M. ;

Van de Kar, N. ;

Zimmerhackl, L. B. .

KIDNEY INTERNATIONAL, 2006, 70 (03) :423-431

[3] Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer:: a case report [J].

Buti, Sebastiano ;

Ricco, Matteo ;

Dalla Chiesa, Matteo ;

Copercini, Bruno ;

Tomasello, Gianluca ;

Brighenti, Matteo ;

Passalacqua, Rodolfo .

ANTI-CANCER DRUGS, 2007, 18 (03) :297-300

[4]

Dahabreh Issa, 2006, BMC Clin Pharmacol, V6, P5, DOI 10.1186/1472-6904-6-5

[5] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[6] Oxaliplatin-induced haemolytic anaemia [J].

Desrame, J ;

Broustet, H ;

de Tailly, PD ;

Girard, D ;

Saissy, JM .

LANCET, 1999, 354 (9185) :1179-1180

[7]

Dold Frederick G, 2003, Ann Intern Med, V139, pE156

[8] Oxaliplatin-induced Evan's syndrome [J].

Earle, CC ;

Chen, WY ;

Ryan, DP ;

Mayer, RJ .

BRITISH JOURNAL OF CANCER, 2001, 84 (03) :441-441

[9] Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome [J].

Franchini, Massimo ;

Zaffanello, Marco ;

Veneri, Dino .

THROMBOSIS RESEARCH, 2006, 118 (02) :177-184

[10]

George James N, 2005, Clin Adv Hematol Oncol, V3, P627

← 1 2 3 →